These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9932709)

  • 1. Blockade of accumbens 5-HT3 receptor down-regulation by ondansetron administered during continuous cocaine administration.
    King GR; Xiong Z; Ellinwood EH
    Eur J Pharmacol; 1999 Jan; 364(2-3):79-87. PubMed ID: 9932709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-HT3 receptor mediated dopamine release in the nucleus accumbens during withdrawal from continuous cocaine.
    Matell MS; King GR
    Psychopharmacology (Berl); 1997 Apr; 130(3):242-8. PubMed ID: 9151358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-HT3 agonist-induced dopamine overflow during withdrawal from continuous or intermittent cocaine administration.
    King GR; Xue Z; Calvi C; Ellinwood EH
    Psychopharmacology (Berl); 1995 Feb; 117(4):458-65. PubMed ID: 7604148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withdrawal from continuous cocaine administration: time dependent changes in accumbens 5-HT3 receptor function and behavioral tolerance.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1999 Mar; 142(4):352-9. PubMed ID: 10229059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of cocaine sensitization and tolerance by the co-administration of ondansetron, a 5-HT3 receptor antagonist, and cocaine.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1997 Mar; 130(2):159-65. PubMed ID: 9106914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blockade of the expression of sensitization and tolerance by ondansetron, a 5-HT3 receptor antagonist, administered during withdrawal from intermittent and continuous cocaine.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1998 Feb; 135(3):263-9. PubMed ID: 9498729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term blockade of the expression of cocaine sensitization by ondansetron, a 5-HT(3) receptor antagonist.
    King GR; Xiong Z; Douglass S; Ellinwood EH
    Eur J Pharmacol; 2000 Apr; 394(1):97-101. PubMed ID: 10771040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
    King GR; Joyner CM; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of continuous 5-HT(3) receptor antagonist administration on the subsequent behavioral response to cocaine.
    King GR; Pinto G; Konen J; Castro G; Tran S; Hilburn C
    Eur J Pharmacol; 2002 Aug; 449(3):253-9. PubMed ID: 12167467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoglossal nerve response to 5-HT3 drugs injected into the XII nucleus and vena cava in the rat.
    Fenik P; Ogawa H; Veasey SC
    Sleep; 2001 Dec; 24(8):871-8. PubMed ID: 11766156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-HT3 receptor antagonists do not modify cocaine place conditioning or the rise in extracellular dopamine in the nucleus accumbens of rats.
    Cervo L; Pozzi L; Samanin R
    Pharmacol Biochem Behav; 1996 Sep; 55(1):33-7. PubMed ID: 8870035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pretreatment with serotonin 5-HT(3) receptor antagonists produces no observable blockade of long-term motor sensitization to cocaine in rats.
    Szumlinski KK; Frys KA; Kalivas PW
    Psychopharmacology (Berl); 2003 Feb; 165(4):329-36. PubMed ID: 12451437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential serotonergic inhibition of in vitro striatal [3H]acetylcholine release in prenatally cocaine-exposed male and female rats.
    Bolaños CA; Trksak GH; Cohen OS; Jackson D
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Dec; 26(7-8):1339-48. PubMed ID: 12502023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conditional involvement of striatal serotonin3 receptors in the control of in vivo dopamine outflow in the rat striatum.
    Porras G; De Deurwaerdère P; Moison D; Spampinato U
    Eur J Neurosci; 2003 Feb; 17(4):771-81. PubMed ID: 12603267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced accumbal dopamine release following 5-HT(2A) receptor stimulation in rats pretreated with intermittent cocaine.
    Yan Q; Reith ME; Yan S
    Brain Res; 2000 Apr; 863(1-2):254-8. PubMed ID: 10773215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of repeated daily treatments with a 5-HT3 receptor antagonist on dopamine neurotransmission and functional activity of 5-HT3 receptors within the nucleus accumbens of Wistar rats.
    Liu W; Thielen RJ; McBride WJ
    Pharmacol Biochem Behav; 2006 Jun; 84(2):370-7. PubMed ID: 16828150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detailed investigations of 5-HT3 compounds in a drug discrimination model.
    De La Garza R; Callahan PM; Cunningham KA
    Pharmacol Biochem Behav; 1996 Jul; 54(3):533-40. PubMed ID: 8743626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of cocaine-induced behavioral sensitization and associated phosphorylation of the NR2B and GluR1 subunits of the NMDA and AMPA receptors.
    Zhang X; Lee TH; Davidson C; Lazarus C; Wetsel WC; Ellinwood EH
    Neuropsychopharmacology; 2007 Feb; 32(2):377-87. PubMed ID: 16794574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-(m-chlorophenyl)-biguanide, a potent high affinity 5-HT3 receptor agonist.
    Kilpatrick GJ; Butler A; Burridge J; Oxford AW
    Eur J Pharmacol; 1990 Jun; 182(1):193-7. PubMed ID: 2144822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of 5-HT3 receptors enhances the electrically evoked release of [3H]noradrenaline in rat brain limbic structures.
    Mongeau R; De Montigny C; Blier P
    Eur J Pharmacol; 1994 May; 256(3):269-79. PubMed ID: 8045271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.